Yearly Archives: 2015

BIPOLAR - AN INSIDER'S TRANSPERSONAL PERSPECTIVE naas siddiqui is a psychiatric survivor and clinician. She has 14 years of experience in the community mental health and...

Remember “Colonel Mustard in the kitchen with the candlestick”? From the game called “Clue” in which you tried to solve a murder mystery? There’s a current, all-too-true and serious mystery involving devastating consequences – even death – for uncounted but vast numbers of people, but in this one the culprits are known to a very few, while their motives remain mysterious. The story starts in 1995, when the man widely considered the world’s most important psychiatrist split a payoff of nearly one million dollars with two colleagues in exchange for doing two patently unethical and illegal things that created the groundwork for a major drug company to market falsely one of the most dangerous psychoactive drugs.

The percentage of seniors in the United States prescribed potentially deadly antipsychotic drugs increases with age. A new study reveals that in the face of serious risks of strokes, fractures, kidney injuries, and death, over seventy-five percent of seniors given antipsychotics do not have a diagnosis for a mental disorder.

Former president of Psychologists for Social Responsibility (PsySR), Roy Eidelson discusses efforts to undermine the Hoffman report which revealed the American Psychologica Association’s collusion in torture. "First, from a familiar playbook, we have the obligatory attack on the patriotism of Hoffman and those who have criticized psychologists’ participation in abusive detention and interrogation operations,” he writes. “The most outrageous example comes from two retired military officers, David Bolgiano and John Taylor. In a recent piece they described the Hoffman Report as a ‘classic attack of cowards’ and also stated, ‘By the publication and release of this report, the APA becomes a willing co-conspirator to the likes of al Qaeda and ISIS.’”

At CounterPunch, Joseph Natoli connects Big Pharma, mass shootings, and rampant inequality. He writes: “The Brave New World soma strategy to deal with a population that, were they not doped up, might violently disrupt that brave new world, is useful if a society is ‘creatively destroying’ a growing number of its population each day. While the poor have daily evidence of their poverty, a collapsing middle class live in the illusion that they are middle class and just a short distance, not from ruin, but from fame and fortune. They are, in short, heading for a catastrophic break-down. Big Pharma is already set to give us all a ‘soft landing.’”

Dr. Mickey Nardo adds to the ongoing discussion about the RAISE study results. He writes: “If there is ‘spin’ in the reporting of this study, we need to know about it. I personally think that it’s more important for RAISE to be reported completely and honestly than whether it comes out like they [or I] want it to come out. We don’t need some sanitized version of RAISE to tell us we need to turn our attention to a full bodied approach to the treatment of First Episode psychotic patients. We all already know that. What we do need is to have our confidence restored in our research community – that they will honestly and clearly report their findings whether they are clean as a whistle or an unholy mess.”

Neuroskeptic weighs in on the controversy over the lack of antipsychotic dose data in the RAISE study and the misleading media coverage. He points out that one of the treatment interventions was a computerized medication management system called COMPASS, which recommends doctors use lower doses than they otherwise might.

Despite safety concerns, a new study reveals that there has been no change in the use of benzodiazepines in the elderly from 2001 to 2010.

In a bellwether case, plaintiffs allege that Pfizer did not adequately warn patients that Zoloft (sertraline) would cause birth defects. The case is scheduled in Federal Court in March, and the verdict will have significant implications for future suits.

PsychCentral presents a new study from the Center for Disease Control and Prevention (CDC) that found that foster care children are three times more likely than other children on Medicaid to receive a diagnosis of ADHD. Overall, more than one in four children in foster care receive such a diagnosis. CDC statistician Melissa Danielson interpreted these results as revealing a “substantial need” for more medical and behavioral services for kids in foster care.

The UK Times reports that pharmaceutical companies are actively lobbying to limit the release of clinical trial data to the public. Rather than limiting results and data to medical journals, new transparency initiatives are pushing for making the information publically available. The push for transparency comes in the wake of the reanalysis of the Study 329 data on paroxetine (marketed as Seroxat and Paxil), which found that the industry study had misconstrued its results.

It was exciting going back to my old stamping ground. Years ago I’d worked in one of the local community mental health teams and had referred many women to the Drayton Park Crisis House. Walking up the steps of the house brought back memories of standing there with desperate and suicidal clients, some of whom had told me that they would rather die than go back into hospital. As you can imagine, to say I had been glad that there was an alternative would have been an understatement.

Access to data is more important than access to information about conflicts of interest. It is only when there is access to the data that we can see if interests are conflicting and take that into account. Problems don’t get solved unless someone is motivated for some reason. We need the bias that pharmaceutical companies bring to bear in their defense of a product, along with the bias of those who might have been injured by a treatment. Both of these biases can distort the picture but it’s when people with differing points of view agree on what is right in front of their noses that we can begin to have some confidence about what we have.

Activist Bonnie Nelson was a force of nature. She and I definitely had our differences. So why am I writing to commemorate her? Among many other reasons, because she would have done the same for me. Bonnie Nelson was a person of principle, and once she decided what was right, the rubber hit the road.

Results of a new study reveal that sixty-nine percent, or more than two-thirds, of patients prescribed antidepressant drugs have never, in their medical history, met the criteria for major depression. The study, published in the Journal of Clinical Psychiatry this month, also found that several demographic factors, like race and gender, were associated with the prescription of antidepressants.

Existential therapist and writer, Jason Dias, claims that there is something deeper and more pervasive than guns, drugs, or mental illness at the bottom of the United States’ mass shooting problem. On aNewDomain he writes: “We have to acknowledge that people who are despairing right now, they’re the sane ones, the normal ones. It makes sense to despair when you’re looked down on, tormented, bullied. When you feel different and you’re alienated. When your culture is alienated. When violence is glorified not by movies and games and television, but by the government, by the news. When violence is fetishized by political parties.”

Last Wednesday, Sesame Street added a new character, Julia, to its roster of characters. In an online story, Julia, who has autism, meets Elmo and Abby and Elmo explains why Julia might sometimes do things a little bit differently. The story was written by Leslie Kimmerman, who has a child with autism, and the entire series will be developed in collaboration with parents, advocates, and people with autism.

Over at CounterPunch, Carl Boggs takes on the knee-jerk mental illness response that pervades the airwaves after every mass shooting. He writes: “What the mental-health fixation lacks is any semblance of historical or social context. Given the persistence of U.S. imperialism and militarism — and mounting fascination with combat and guns in a society transfigured by its warfare state — Washington remains a thriving center of global violence: repeated armed interventions abroad have found their domestic parallel in the world’s largest prison system, a deepening gun culture, home-bred terrorism, police atrocities, and a media culture filled with spectacles of warfare and bloodshed.”

Last Tuesday, The New York Times and several other outlets (including Mad In America) reported on the highly-touted results of a study on psychosocial treatment for patients diagnosed with schizophrenia. Now, claims made about the study, which the ‘Times called “the most rigorous trial to date,” are coming under increased scrutiny.

Mindpower: Auður will be blogging about her work in Iceland, as the director of the foundation of Hugarafl (Mindpower), as well as their goals...

Mindpower Auður Axelsdóttir is an occupational therapist from Reykjavík, Iceland. She is the director of Hugarafl (e. Mindpower) and recovery center, which operates within the...

Minn Post did a feature story last week on Vail Place, an alternative mental health treatment center run on a community “clubhouse” model where the nearly 900 members and staff work side by side to run the center’s activities. Vail Place was founded in Hopkins, Minnesota in the early eighties by mental health activists and family members as a community for psychosocial rehabilitation. “The work isn’t therapy,” a member explains. “It’s growth. It’s ‘I cans’ rather than ‘I can'ts.’ And that’s important for mental health and survival.”

Writing on his critical psychiatry blog, Duncan Double critiques Joe Herbert’s piece on “Why can't we treat mental illness by fixing the brain?” in Aeon. While Herbert admits that there is a "mysterious and seemingly unfathomable gap" between psychology and neuroscience, which "bedevils not only psychiatry, but all attempts to understand the meaning of humanity,” he goes on to speculate that someday psychiatrists will be able to relate symptoms to brain activity.

The Boston Globe highlights a new book, “In the Mind Fields: Exploring the New Science of Neuropsychoanalysis,” by Casey Schwartz, which explores the importance on psychoanalysis in the age of neuroscience. The author explains that the psychoanalytic approach offers “an absolutely incomparable depth and attention to the specifics of each individual person and their reality. This is exactly what’s disappearing in neuroscience: the quirks, the particularities, the subtleties of the individual.”

This week the drug monitoring and patients' rights website, RxISK, launched the Centre for Medication Withdrawal, a page dedicated to establishing what causes dependence and how to treat it.